PAPER
One-Carbon Homologation of Aldehydes to N-(a-Haloacyl)benzotriazoles
3233
1-[(E)-2-Phenyl-1-ethenyl]-1H-1,2,3-benzotriazole (2a)
Yield: 64%; white microcrystals; mp 112–114 °C (Lit.13 115–
116 °C).
1H NMR (300 MHz, CDCl3): d = 7.32–7.61 (m, 8 H), 7.77 (d,
J = 8.4 Hz, 1 H), 7.94 (dd, J = 12.9, 1.1 Hz, 1 H), 8.12 (d, J = 8.4
Hz, 1 H).
7.2 Hz, 1 H), 7.25–7.39 (m, 2 H), 7.46 (m, 1 H), 7.63 (d, J = 8.4 Hz,
1 H), 8.05 (d, J = 8.4 Hz, 1 H).
13C NMR (75 MHz, CDCl3): d = 13.4, 22.2, 32.0, 109.9, 119.8,
122.7, 123.1, 124.1, 127.7, 131.2, 145.9.
1-(1-Nonenyl)-1H-1,2,3-benzotriazole (2h)
Yield: 38%; colorless microcrystals; mp 43–44 °C (Lit.13 15 °C).
13C NMR (75 MHz, CDCl3): d = 110.3, 120.7, 121.3, 122.0, 124.9,
126.8, 128.5, 128.7, 129.3, 131.7, 134.6, 146.6.
1H NMR (300 MHz, CDCl3): d = 0.92 (t, J = 6.9 Hz, 3 H), 1.25–
1.69 (m, 10 H), 2.35 (qd, J = 7.5 Hz, 1.2 Hz, 2 H), 6.54 (dt, J = 14.1,
7.2 Hz, 1 H), 7.30–7.44 (m, 2 H), 7.52–7.58 (m, 1 H), 7.68 (d,
J = 8.4 Hz, 1 H), 8.10 (d, J = 8.4 Hz, 1 H).
13C NMR (75 MHz, CDCl3): d = 14.0, 22.6, 28.9, 29.0, 29.1, 30.1,
31.7, 110.0, 120.1, 122.7, 123.7, 124.2, 127.8, 131.3, 146.0.
1-[2-(4-Methylphenyl)-1-ethenyl]-1H-1,2,3-benzotriazole (2b)
Yield: 65%; white microcrystals; mp 147–150 °C (Lit.13 148–
151 °C).
1H NMR (300 MHz, CDCl3): d = 2.38 (s, 3 H), 7.21 (d, J = 8.0 Hz,
2 H), 7.39–7.45 (m, 4 H), 7.56 (t, J = 7.8 Hz, 1 H), 7.75 (d, J = 8.4
Hz, 1 H), 7.88 (d, J = 14.7 Hz, 1 H), 8.10 (d, J = 8.4 Hz, 1 H).
Anal. Calcd for C15H21N3: C, 74.04; H, 8.70; N, 17.27. Found: C,
73.76; H, 8.61; N, 17.27.
13C NMR (75 MHz, CDCl3): d = 21.3, 110.0, 120.3, 120.9, 121.1,
124.5, 126.4, 128.1, 129.6, 131.4, 131.4, 138.5, 146.2.
1-(4-Phenyl-1-butenyl)-1H-1,2,3-benzotriazole (2i)
Yield: 41%; colorless microcrystals; mp 127–128 °C.
1-[2-(2-Methylphenyl)-1-ethenyl]-1H-1,2,3-benzotriazole (2c)
Yield: 53%; white microcrystals; mp 101–102 °C.
1H NMR (300 MHz, CDCl3): d = 2.48 (s, 3 H), 7.26–7.29 (m, 3 H),
7.42–7.47 (m, 1 H), 7.57–7.62 (m, 2 H), 7.67–7.83 (m, 3 H), 8.12
(d, J = 8.4 Hz, 1 H).
13C NMR (75 MHz, CDCl3): d = 19.9, 109.9, 119.2, 120.3, 122.3,
124.5, 125.3, 126.4, 128.2, 128.4, 130.6, 131.4, 133.3, 136.3, 146.2.
1H NMR (300 MHz, CDCl3): d = 2.61–2.68 (m, 2 H), 2.89 (t,
J = 7.5 Hz, 2 H), 6.47–6.57 (m, 1 H), 7.16–7.40 (m, 7 H), 7.47–
7.58 (m, 2 H), 8.06 (d, J = 8.4 Hz, 1 H).
13C NMR (75 MHz, CDCl3): d = 29.3, 35.1, 109.5, 119.9, 120.5,
124.2, 126.0, 127.7, 128.3, 128.4, 132.7, 140.9, 145.0.
Anal. Calcd for C16H15N3: C, 77.08; H, 6.06; N, 16.85. Found: C,
77.34; H, 6.04; N, 16.65.
Anal. Calcd for C15H13N3: C, 76.57; H, 5.57; N, 17.86. Found: C,
76.50; H, 5.64; N, 18.13.
1-[2-(2-Thienyl)ethenyl]-1H-1,2,3-benzotriazole (2j)
Yield: 53%; white microcrystals; mp 90–92 °C.
1-(1-Butenyl)-1H-1,2,3-benzotriazole (2d)14
Yield: 54%; colorless oil.
1H NMR (300 MHz, CDCl3): d = 1.20 (t, J = 7.5 Hz, 3 H), 2.30–
2.40 (m, 2 H), 6.55 (dt, J = 14.0, 6.9 Hz, 1 H), 7.29 (d, J = 14.2 Hz,
1 H), 7.35–7.41 (m, 1 H), 7.48–7.54 (m, 1 H), 7.65 (d, J = 8.4 Hz,
1 H), 8.06 (d, J = 8.2 Hz, 1 H).
1H NMR (300 MHz, CDCl3): d = 7.03–7.06 (m, 1 H), 7.17 (d,
J = 3.3 Hz, 1 H), 7.27 (d, J = 4.8 Hz, 1 H), 7.39–7.44 (m, 1 H),
7.53–7.62 (m, 2 H), 7.68–7.79 (m, 2 H), 8.10 (d, J = 8.4 Hz, 1 H).
13C NMR (75 MHz, CDCl3): d = 109.7, 114.5, 120.1, 120.3, 124.5,
125.1, 127.4, 127.7, 128.1, 131.1, 138.1, 145.9.
Anal. Calcd for C12H9N3S: C, 63.41; H, 3.99; N, 18.49. Found: C,
63.64; H, 3.94; N, 18.28.
13C NMR (75 MHz, CDCl3): d = 13.7, 23.6, 110.3, 120.3, 122.5,
124.4, 125.3, 128.0, 131.6, 146.3.
Preparation of 1-(1-Bromovinyl)benzotriazoles 3a–j; General
Procedure
1-(3-Methyl-1-butenyl)-1H-1,2,3-benzotriazole (2e)14
Yield: 64%; colorless oil.
1H NMR (300 MHz, CDCl3): d = 1.20 (d, J = 6.7, 6 H), 2.59–2.66
(m, 1 H), 6.50 (dd, J = 14.4, 7.2 Hz, 1 H), 7.27 (d, J = 14.4 Hz, 1 H),
7.35–7.40 (m, 1 H), 7.48–7.53 (m, 1H), 7.65 (d, J = 8.2 Hz, 1 H),
8.06 (d, J = 8.1 Hz, 1 H).
To a solution of vinylbenzotriazole 2 (11 mmol) in CH2Cl2 (20 mL)
was added Br2 (1.84 g, 11.5 mmol) in CH2Cl2 (5 mL) at 0 °C and the
mixture was stirred at r.t. for 4 h. Et3N (6 mL) was added at 0 °C and
the mixture was stirred at r.t. for 14 h. The reaction mixture was fil-
tered and the filtrate was washed with HCl (1 N, 10 mL), brine (10
mL) and dried over MgSO4. Evaporation of the solvent gave a crude
product that was purified by flash column chromatography (hex-
anes–EtOAc, 19:1).
13C NMR (75 MHz, CDCl3): d = 22.2, 29.4, 110.0, 120.0, 121.0,
124.1, 127.7, 130.1, 131.3, 146.0.
1-[(EZ)-4-Methyl-1-pentenyl]-1H-1,2,3-benzotriazole (2f)
Yield: 51%; colorless oil.
1-(1-Bromo-2-phenyl-1-ethenyl)-1H-1,2,3-benzotriazole (3a)
Yield: 80%; white microcrystals; mp 78–80 °C.
1H NMR (300 MHz, CDCl3): d = 6.75 (d, J = 7.5 Hz, 2 H), 7.18–
7.08 (m, 3 H), 7.51–7.41 (m, 4 H), 8.13 (d, J = 8.1 Hz, 1 H).
13C NMR (75 MHz, CDCl3): d = 108.8, 110.4, 120.4, 124.9, 128.0,
128.7, 128.9, 129.3, 131.8, 132.6, 136.1, 145.6.
1H NMR (300 MHz, CDCl3): d = 1.01 (0.91) (d, J = 6.6 Hz, 6 H),
1.73–1.90 (m, 1 H), 2.19–2.24 (2.31–2.36) (m, 2 H), 6.45–6.55
(5.84–5.92) (m, 1 H), 7.28 (7.04) (d, J = 14.1 Hz, 1 H), 7.37–7.42
(m, 1 H), 7.49–7.55 (7.65–7.67) (m, 2 H), 8.06–8.09 (m, 1 H).
13C NMR (75 MHz, CDCl3): d = 22.2, 28.3 (30.8), 39.2 (36.3),
110.0 (109.6), 120.1 (119.8), 122.2 (120.6), 123.4, 124.2 (124.0),
127.8 (127.6), 128.7, 131.3, 146.0 (145.1).
Anal. Calcd for C14H10BrN3: C, 56.02; H, 3.36; N, 14.00. Found: C,
55.98; H, 3.20; N, 13.84.
Anal. Calcd for C12H15N3: C, 71.61; H, 7.51; N, 20.88. Found: C,
71.30; H, 7.54; N, 21.08.
1-[1-Bromo-2-(4-methylphenyl)-1-ethenyl]-1H-1,2,3-benzotria-
zole (3b)
Yield: 61%; white needles; mp 158–160 °C.
1-(1-Pentenyl)-1H-1,2,3-benzotriazole (2g)12
Yield: 59%; yellow oil.
1H NMR (300 MHz, CDCl3): d = 1.00 (t, J = 7.2 Hz, 3 H), 1.52–
1.64 (m, 2 H), 2.28 (dq, J = 7.5 Hz, 1.5 Hz, 2 H), 6.49 (dt, J = 14.4,
1H NMR (300 MHz, CDCl3): d = 2.20 (s, 3 H), 6.61 (d, J = 8.1 Hz,
2 H), 6.89 (d, J = 8.1 Hz, 2 H), 7.37 (s, 1 H), 7.54–7.42 (m, 3 H),
8.13 (d, J = 8.1 Hz, 1 H).
Synthesis 2006, No. 19, 3231–3237 © Thieme Stuttgart · New York